Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.
Authors
Lal, RHillerdal, G
Shah, R
Crosse, B
Thompson, J
Nicolson, M
Vikström, A
Potter, V
Visseren-Grul, C
Lorenzo, M
D'yachkova, Y
Bourayou, N
Summers, Yvonne J
Affiliation
Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.Issue Date
2015-08
Metadata
Show full item recordAbstract
To evaluate the feasibility and adherence to home delivery (HD) of pemetrexed maintenance treatment in patients with advanced non-squamous non-small cell lung cancer (nsqNSCLC).Citation
Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer. 2015, 89 (2):154-60 Lung CancerJournal
Lung CancerDOI
10.1016/j.lungcan.2015.05.003PubMed ID
26101013Type
ArticleLanguage
enISSN
1872-8332ae974a485f413a2113503eed53cd6c53
10.1016/j.lungcan.2015.05.003
Scopus Count
Collections
Related articles
- Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial.
- Authors: Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C
- Issue date: 2012 Mar
- Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
- Authors: Belani CP, Brodowicz T, Ciuleanu TE, Krzakowski M, Yang SH, Franke F, Cucevic B, Madhavan J, Santoro A, Ramlau R, Liepa AM, Visseren-Grul C, Peterson P, John WJ, Zielinski CC
- Issue date: 2012 Mar
- Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients.
- Authors: Buti S, Bordi P, Tiseo M, Bria E, Sperduti I, Di Maio M, Panni S, Novello S, Rapetti SG, Pilotto S, Genestreti G, Rossi A, Pezzuolo D, Camisa R, Tortora G, Ardizzoni A
- Issue date: 2015 Jun
- Assessment of interfering factors and clinical risk associated with discontinuation of pemetrexed maintenance therapy in advanced non-squamous non-small cell lung cancer.
- Authors: Shen L, Niu X, Jian H, Xu Y, Yu Y, Lu S
- Issue date: 2017 Sep
- Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer.
- Authors: Karayama M, Inui N, Fujisawa T, Enomoto N, Nakamura Y, Kuroishi S, Yokomura K, Koshimizu N, Sato M, Toyoshima M, Shirai T, Masuda M, Yamada T, Imokawa S, Suda T
- Issue date: 2016 May